Q32 Bio price target lowered to $20 from $80 at Oppenheimer
Oppenheimer lowered the firm’s price target on Q32 Bio (QTTB) to $20 from $80 and keeps an Outperform rating on the shares.
Noom Offers Oral Medications For Weight Loss Starting at $29
A $29 entry price helps provide accessibility for people pursuing weight loss goalsService includes all features of Noom Med ...